データなし
データなし
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
Adaptimmune to Participate in Two Bank Conferences This September
Individual Investors Who Own 39% Along With Institutions Invested in Adaptimmune Therapeutics Plc (NASDAQ:ADAP) Saw Increase in Their Holdings Value Last Week
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading
European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Open Week Strong Monday Trading
データなし
データなし